Patent details

300982 Product Name: Certolizumab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300982
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP3059314
Status:
Withdrawn
Application number:
300982
Procedural language:
Dutch
First Applicant Residence Country:
Belgium (BE)

Marketing Authorization

Marketing Authorization Number:
EU/1/09/544/001-002
Marketing Authorization Type:
EEA
Marketing Authorization Date:
06/10/2009
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
24/04/2019
First Marketing Authorization date:
06/10/2009
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
26/04/2019
SPC/SPC Extension Expiration Date:
05/10/2024
Lapsed By Expiration Date:
Withdrawal date:
23/10/2019
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
24/04/2019
 
 

 

Name:
UCB Pharma, S.A.
Address:
Allée de la Recherche 60, 1070 BRUXELLES, Belgium (BE)

Agent

Name:
ir. H.A. Witmans c.s.
From:
24/04/2019
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
44/19
Publication date:
30/10/2019
Description:
Lapse or annulment

2

Bulletin Heading:
VRB
Journal edition number:
19/19
Publication date:
08/05/2019
Description:
Corrections on earlier publications

3

Bulletin Heading:
SPC
Journal edition number:
18/19
Publication date:
01/05/2019
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date Document type Document Description Number of pages File Type
29/10/2019 Outgoing Correspondence Outgoing Letter 1 PDF /2/7/8/2/0/0800402872/docs/300982_4_outgoingcorrespondence20191029123707693.pdf
24/10/2019 Incoming Correspondence Paper Withdrawal of a request 1 PDF /2/7/8/2/0/0800402872/docs/300982_3_incomingcorrespondencepaper20191025112138682.pdf
06/05/2019 Front Page Front Page 1 PDF /2/7/8/2/0/0800402872/docs/300982_0_i9frontpage20190506135043015.pdf
06/05/2019 Publication Publication 1 PDF /2/7/8/2/0/0800402872/docs/300982_10_i9document20190506135044125.pdf
03/05/2019 Outgoing Correspondence Confirmation receipt request 1 PDF /2/7/8/2/0/0800402872/docs/300982_8_271283l174.pdf
25/04/2019 SPC Documents Summary of the characteristics of the product 16 PDF /2/7/8/2/0/0800402872/docs/300982_1_supplprotectioncertificate20190426105158126.pdf
25/04/2019 SPC Documents Marketing Authorization SPC 4 PDF /2/7/8/2/0/0800402872/docs/300982_5_supplprotectioncertificate20190426105158060.pdf
25/04/2019 SPC Documents Accompanying letter SPC 2 PDF /2/7/8/2/0/0800402872/docs/300982_6_supplprotectioncertificate20190426105157992.pdf
25/04/2019 SPC Documents Annex SPC 22 PDF /2/7/8/2/0/0800402872/docs/300982_7_supplprotectioncertificate20190426105158315.pdf
25/04/2019 SPC Documents Annex SPC 3 PDF /2/7/8/2/0/0800402872/docs/300982_9_supplprotectioncertificate20190426105158239.pdf
25/04/2019 Application Form First filed application form 3 PDF /2/7/8/2/0/0800402872/docs/300982_11_applicationform20190426105157841.pdf
24/04/2019 SPC Documents Mail SPC 53 PDF /2/7/8/2/0/0800402872/docs/300982_2_supplprotectioncertificate20190426015244932.pdf